Regeneron Pharma (REGN) PT Lowered to $525 at Morgan Stanley
Tweet
Share
E-mailGet Alerts REGN Hot Sheet
Price: $805.93 --0%
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 20
Rating Summary:
29 Buy, 19 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 6 | Down: 9 | New: 20
Join SI Premium – FREE
Morgan Stanley analyst Matthew Harrison lowered the price target on Regeneron Pharma (NASDAQ: REGN) to $525.00 (from $553.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- Alpha Cognition Inc (ACOG) PT Raised to $20 at H.C. Wainwright
- Leeno Industrial (058470:KS) PT Raised to KRW91,000 at Nomura/Instinet
- JCR Pharmaceuticals Co Ltd (4552:JP) PT Raised to JPY540 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
